COMMUNIQUÉS West-GlobeNewswire

Glass House Brands to Host Second Quarter 2024 Conference Call on August 13, 2024
30/07/2024
LONG BEACH, Calif. and TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company” (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), one of the fastest- [...]
Inari Medical Reports Second Quarter 2024 Financial Results
30/07/2024
IRVINE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
30/07/2024
SILVER SPRING, Md., July 30, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, today announced that it will release its second quarter 2024 [...]
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
30/07/2024
MOUNTAIN VIEW, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for [...]
FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
30/07/2024
Pamrevlumab arm of the Precision Promise SM study in metastatic pancreatic cancer, sponsored and conducted by the Pancreatic Cancer Action Network (PanCAN), did not meet the primary endpoint of overall survival as [...]
Stryker reports second quarter 2024 operating results
30/07/2024
Portage, Michigan, July 30, 2024 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2024: Second Quarter Results Reported net sales increased 8.5% to $5.4 billion Organic net [...]
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
30/07/2024
Confirming cash runway guidance into 2026 ROCKVILLE, MD, July 30, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and [...]
Teknova to Report Second Quarter 2024 Financial Results on August 13, 2024
30/07/2024
HOLLISTER, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
30/07/2024
TX45 is an Fc-relaxin fusion protein being evaluated in patients with Group 2 Pulmonary Hypertension (PH) due to Heart Failure with Preserved Ejection Fraction (HFpEF), a serious condition estimated to affect over 600, [...]
Replimune to Present at Two Upcoming Investor Conferences
30/07/2024
WOBURN, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced [...]
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
30/07/2024
JUPITER, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a biotechnology company focused on the efficient large-scale manufacture of [...]
Pacira BioSciences Reports Second Quarter 2024 Financial Results
30/07/2024
-- Conference call today at 4:30 p.m. ET -- TAMPA, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative [...]
ADvantage Therapeutics Announces Breakthrough Findings in Alzheimer's Disease Treatment: AD04TM shows immediate symptomatic and disease-modifying properties
30/07/2024
PHILADELPHIA, July 30, 2024 (GLOBE NEWSWIRE) -- ADvantage Therapeutics today announced groundbreaking results from a study on AD04™, a novel therapeutic candidate for Alzheimer's disease. Scientists from ADvantage [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 30 - 2024
30/07/2024
Aggregated presentation by day and by market Purchases of own shares from July 22th to 26th, 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 30 - 2024
30/07/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 au 26 juillet 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
H1 2024 Results - Focus-27 strategic plan on track with timely execution of the operational roadmap
30/07/2024
Press Release Paris, 30th July 2024 Net Sales down 9.6% year-on-year – Core EBITDA margin at 10.6% Accelerated commercial momentum with clients other than Sanofi, with Net Sales up 2.9%, excluding the Brindisi site, [...]
RESULTATS DU PREMIER SEMESTRE 2024 - Le plan stratégique Focus-27 est en bonne voie avec une exécution dans les délais de la feuille de route opérationnelle
30/07/2024
COMMUNIQUE DE PRESSE Paris, le 30 juillet 2024 Chiffre d’affaires en baisse de 9,6 % en variation annuelle - Marge de Core EBITDA de 10,6% Accélération de la dynamique commerciale avec les clients autres que Sanofi, [...]
La Croix-Rouge canadienne annonce une aide financière pour les personnes évacuées de Jasper en raison des feux de forêt en Alberta
30/07/2024
Les ménages contraints d’évacuer leur résidence principale à Jasper recevront 750 $ OTTAWA, Ontario, 30 juill. 2024 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne a annoncé aujourd’hui qu’elle versera un montant unique [...]
BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms
30/07/2024
July 30, 2024 News Release BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms ADLM 2024 Conference – Chicago, July 30, 2024 [...]

Pages